These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

690 related items for PubMed ID: 25716399

  • 1. Body mass index and gonadotropin hormones (LH & FSH) associate with clinical symptoms among women with polycystic ovary syndrome.
    Esmaeilzadeh S, Andarieh MG, Ghadimi R, Delavar MA.
    Glob J Health Sci; 2014 Sep 28; 7(2):101-6. PubMed ID: 25716399
    [Abstract] [Full Text] [Related]

  • 2. [Preliminary study on the value of ratio of serum luteinizing hormone/follicle-stimulating hormone in diagnosis of polycystic ovarian syndrome among women with polycystic ovary].
    Ma CS, Lin Y, Zhang CH, Xu H, Li YF, Zhang SC, Tan Y, Quan S, Xing FQ.
    Zhonghua Fu Chan Ke Za Zhi; 2011 Mar 28; 46(3):177-80. PubMed ID: 21575449
    [Abstract] [Full Text] [Related]

  • 3. Inappropriate gonadotropin secretion in polycystic ovary syndrome.
    Hsu MI, Liou TH, Liang SJ, Su HW, Wu CH, Hsu CS.
    Fertil Steril; 2009 Apr 28; 91(4):1168-74. PubMed ID: 18325508
    [Abstract] [Full Text] [Related]

  • 4. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome.
    Taylor AE, McCourt B, Martin KA, Anderson EJ, Adams JM, Schoenfeld D, Hall JE.
    J Clin Endocrinol Metab; 1997 Jul 28; 82(7):2248-56. PubMed ID: 9215302
    [Abstract] [Full Text] [Related]

  • 5. Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome.
    Sharquie KE, Al-Bayatti AA, Al-Ajeel AI, Al-Bahar AJ, Al-Nuaimy AA.
    Saudi Med J; 2007 Jul 28; 28(7):1039-43. PubMed ID: 17603706
    [Abstract] [Full Text] [Related]

  • 6. Ovarian morphology as a predictor of hormonal values in polycystic ovary syndrome.
    van der Westhuizen S, van der Spuy ZM.
    Ultrasound Obstet Gynecol; 1996 May 28; 7(5):335-41. PubMed ID: 8774098
    [Abstract] [Full Text] [Related]

  • 7. Clinical and metabolic characteristics of Turkish adolescents with polycystic ovary syndrome.
    Ates S, Aydın S, Ozcan P, Soyman Z, Gokmen Karasu AF, Sevket O.
    J Obstet Gynaecol; 2018 Feb 28; 38(2):236-240. PubMed ID: 28920502
    [Abstract] [Full Text] [Related]

  • 8. Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women.
    Liou TH, Yang JH, Hsieh CH, Lee CY, Hsu CS, Hsu MI.
    Fertil Steril; 2009 Dec 28; 92(6):1960-5. PubMed ID: 18980763
    [Abstract] [Full Text] [Related]

  • 9. Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents.
    Li L, Chen X, He Z, Zhao X, Huang L, Yang D.
    J Pediatr Adolesc Gynecol; 2012 Dec 28; 25(6):390-5. PubMed ID: 23089573
    [Abstract] [Full Text] [Related]

  • 10. Anteroposterior diameter of the infrarenal abdominal aorta is higher in women with polycystic ovary syndrome.
    Ciccone MM, Favale S, Bhuva A, Scicchitano P, Caragnano V, Lavopa C, De Pergola G, Loverro G.
    Vasc Health Risk Manag; 2009 Dec 28; 5(3):561-6. PubMed ID: 19590590
    [Abstract] [Full Text] [Related]

  • 11. Follicle Stimulating Hormone (LH: FSH) Ratio in Polycystic Ovary Syndrome (PCOS) - Obese vs. Non- Obese Women.
    Saadia Z.
    Med Arch; 2020 Aug 28; 74(4):289-293. PubMed ID: 33041447
    [Abstract] [Full Text] [Related]

  • 12. Influence of anthropometric measurements on abnormal gonadotropin secretion in women with polycystic ovary syndrome.
    Haider S, Mannan N, Khan A, Qureshi MA.
    J Coll Physicians Surg Pak; 2014 Jul 28; 24(7):463-6. PubMed ID: 25052966
    [Abstract] [Full Text] [Related]

  • 13. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels.
    Piouka A, Farmakiotis D, Katsikis I, Macut D, Gerou S, Panidis D.
    Am J Physiol Endocrinol Metab; 2009 Feb 28; 296(2):E238-43. PubMed ID: 18957615
    [Abstract] [Full Text] [Related]

  • 14. Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case-control study.
    Zhang HY, Guo CX, Zhu FF, Qu PP, Lin WJ, Xiong J.
    Arch Gynecol Obstet; 2013 Mar 28; 287(3):525-31. PubMed ID: 23108387
    [Abstract] [Full Text] [Related]

  • 15. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients.
    Balen AH, Conway GS, Kaltsas G, Techatrasak K, Manning PJ, West C, Jacobs HS.
    Hum Reprod; 1995 Aug 28; 10(8):2107-11. PubMed ID: 8567849
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of polycystic ovarian changes and polycystic ovary syndrome in premenopausal women with treated type 2 diabetes mellitus.
    Kelestimur F, Unluhizarci K, Baybuga H, Atmaca H, Bayram F, Sahin Y.
    Fertil Steril; 2006 Aug 28; 86(2):405-10. PubMed ID: 16762349
    [Abstract] [Full Text] [Related]

  • 17. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
    Sahmay S, Atakul N, Aydogan B, Aydin Y, Imamoglu M, Seyisoglu H.
    Acta Obstet Gynecol Scand; 2013 Dec 28; 92(12):1369-74. PubMed ID: 23980726
    [Abstract] [Full Text] [Related]

  • 18. Ultrasonography of the ovaries and its correlation with clinical and endocrine parameters in infertile women with PCOS.
    Sikka P, Gainder S, Dhaliwal LK, Bagga R, Sialy R, Sahdev S.
    Int J Fertil Womens Med; 2007 Dec 28; 52(1):41-7. PubMed ID: 17987887
    [Abstract] [Full Text] [Related]

  • 19. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
    Yang HY, Ma Y, Lu XH, Liang XH, Suo YJ, Huang ZX, Lu DC, Qin YF, Luo ZJ.
    Ann Endocrinol (Paris); 2015 Oct 28; 76(5):620-7. PubMed ID: 26514948
    [Abstract] [Full Text] [Related]

  • 20. Exploration of the role of anti-Mullerian hormone and LH/FSH ratio in diagnosis of polycystic ovary syndrome.
    Le MT, Le VNS, Le DD, Nguyen VQH, Chen C, Cao NT.
    Clin Endocrinol (Oxf); 2019 Apr 28; 90(4):579-585. PubMed ID: 30636332
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.